UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Hanmi posts ₩245.7 billion in Q1 sales
Hanmi Pharmaceutical said Thursday that it recorded 245.7 billion won ($228...
by Lee Han-soo
|
2018-05-03 14:52
라인
How much cheaper will Keytruda be as first-line treatment?
The pharmaceutical industry is paying attention to how much the price of MS...
by Nam Doo-hyun
|
2018-05-03 14:51
라인
SK Chemicals approves spinoff of its vaccine biz
SK Chemicals said Thursday that the company’s board of directors has approv...
by Lee Han-soo
|
2018-05-03 14:33
라인
Abbvie applies for European marketing approval for investigational psoriasis therapy
Illinois-based pharmaceutical firm Abbvie has submitted a marketing authori...
by Marian Chu
|
2018-05-03 13:12
라인
Will Deloitte’s prediction of clinical success work?
“We have developed the world’s first machine learning solution that predict...
by Park Gi-taek
|
2018-05-03 13:12
라인
Roche gets expanded reimbursement for ovarian cancer therapy
Roche Korea (CEO: Matt Sause) said that its targeted therapy Avastin (ingre...
by Marian Chu
|
2018-05-02 18:17
라인
Patients satisfied with Neofect’s rehab solution’: Stanford
Neofect said Wednesday that Stanford University has presented a research re...
by Lee Han-soo
|
2018-05-02 17:39
라인
Lilly Korea’s gastric cancer drug gets expanded reimbursement
The Korean branch of Eli Lilly and Company said that its gastric cancer the...
by Marian Chu
|
2018-05-02 17:13
라인
Samsung BioLogics denies accounting irregularities
Shim Byung-hwa (left), Samsung BioLogics’ business innovation team leader, ...
by Lee Han-soo
|
2018-05-02 17:12
라인
JW Pharma, Syntekabio agree to develop new drugs using AI
JW Pharmaceutical said Wednesday that it has signed a memorandum of underst...
by Lee Han-soo
|
2018-05-02 16:33
라인
N. Korea has 3.3 doctors per 1,000 people, similar to S. Korea
Since the inter-Korean summit on Friday, healthcare experts are increasingl...
by Song Soo-youn
|
2018-05-02 16:30
라인
Gtree presents dry eye treatment at US conference
Gtree BNT said Wednesday that it has presented data regarding RGN-259, a dr...
by Lee Han-soo
|
2018-05-02 15:37
라인
Bayer’s liver cancer drug gets more reimbursement as 2nd line therapy
Bayer Korea’s targeted liver cancer therapy Stivarga (ingredient: regorafen...
by Marian Chu
|
2018-05-02 15:36
라인
Genexine, Roche to research combination treatment for cancer
Genexine and its U.S. subsidiary NeoImmuneTech said Wednesday they have sig...
by Lee Han-soo
|
2018-05-02 15:13
라인
‘German reunification in healthcare took 2 years’
Healthcare experts are paying attention to how East Germany and West German...
by Song Soo-youn
|
2018-05-02 15:12
라인
[Interview with foreign envoys] ‘Medical investment in Pakistan full of opportunities’
Pakistan has been a long partner in Korea’s medical field since Korea and P...
by Lee Han-soo
|
2018-05-01 07:47
라인
365mc operates customized hospital for foreign patients in Daejeon
The “plastic surgery Hallyu” (Korean wave of cosmetic surgery) is sweeping ...
by Song Soo-youn
|
2018-05-01 07:46
라인
[Doctors with Patents] ‘Convergence needed to bolster Korean biomedical competitiveness’
Song Si-young, dean of Yonsei University College of Medicine, physician, an...
by Marian Chu
|
2018-05-01 07:46
라인
US court dismisses Medytox’s suit against Daewoong without prejudice
The war of nerves between Daewoong Pharmaceuticals and Medytox over the ori...
by Lee Han-soo
|
2018-04-30 17:31
라인
Korean pharma firms target rare diseases to enter US market
Domestic pharmaceutical companies are targeting the U.S. market with rare d...
by So Jae-hyeon
|
2018-04-30 16:42
-
이전
221
222
223
224
225
226
227
228
229
230
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top